Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
“Attended an outstanding AI conference at Yale School of Medicine today, focused on the rapidly evolving role of artificial intelligence in clinical medicine, research, and education.
A few key highlights:
Rohan Khera (Yale)
Discussed how AI is transforming cardiovascular care—from predictive analytics to accelerating clinical discovery through large-scale data science.
Jeremy Warner (Brown)
Explored the future of knowledge representation in hematology and oncology, emphasizing structured data and interoperability to support clinical decision-making.
Sharma (Yale)
Presented the use of AI in preventing recurrent stroke, highlighting opportunities for early risk identification and personalized intervention.
Jaideep S. Talwalkar (Yale)
Shared insights on integrating AI into medical education, including how it is reshaping clinical skills training and learner engagement.
What stood out most was the clear shift from theoretical AI applications to real-world clinical implementation, impacting patient outcomes, trial design, and medical training.”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia